PharmaBlock Sciences Nanjing Inc Class A (300725) — Strategic Asset Allocation Index
PharmaBlock Sciences Nanjing Inc Class A (300725) has a Strategic Asset Allocation Index of 62.4% as of June 2023. Strategic assets (PP&E of CN¥1.73 Billion plus long-term investments of CN¥-) total CN¥1.73 Billion, measured against net assets of CN¥2.77 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of PharmaBlock Sciences Nanjing Inc Class A to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
PharmaBlock Sciences Nanjing Inc Class A Strategic Asset Allocation Index (2016–2022)
This chart shows how PharmaBlock Sciences Nanjing Inc Class A's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 62.4%, representing strategic assets of CN¥1.73 Billion against net assets of CN¥2.77 Billion CNY. For live market cap and overall valuation, see market value of PharmaBlock Sciences Nanjing Inc Class A.
Annual Strategic Asset Allocation Index for PharmaBlock Sciences Nanjing Inc Class A (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for PharmaBlock Sciences Nanjing Inc Class A from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 300725 book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 62.5% | CN¥1.66 Billion | CN¥1.66 Billion | CN¥- | CN¥2.66 Billion | ▲ +17.9 pp |
| 2021 | 44.6% | CN¥1.17 Billion | CN¥1.17 Billion | CN¥- | CN¥2.63 Billion | ▲ +28.3 pp |
| 2020 | 16.3% | CN¥309.36 Million | CN¥309.36 Million | CN¥- | CN¥1.89 Billion | ▼ -18.5 pp |
| 2019 | 34.8% | CN¥257.69 Million | CN¥257.69 Million | CN¥- | CN¥740.87 Million | ▲ +13.8 pp |
| 2018 | 21.0% | CN¥125.88 Million | CN¥125.88 Million | CN¥- | CN¥599.73 Million | ▲ +2.5 pp |
| 2017 | 18.5% | CN¥93.04 Million | CN¥93.04 Million | CN¥- | CN¥503.59 Million | ▼ -11.0 pp |
| 2016 | 29.5% | CN¥74.98 Million | CN¥74.98 Million | CN¥- | CN¥254.15 Million | — |